|
We can now see further evidence that near infrared light stimulation can positively influence beta amyloid production and this can have a significant impact on people with cognitive decline from neurodegenerative Alzheimer's and Parkinson's disease. Quietmind Fdn. is using these technologies in our current clinical trials. Call 610-940-0488 for details. 
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
QMF NewsOur team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. Archives
January 2021
Categories
All
|
||
RSS Feed
Our mission is to study, provide and promote drug-free, low-cost, noninvasive approaches to understanding and treating disorders that affect people's thinking, behavior, and movement.
Office HoursMonday & Thursday: 11am - 6pm
In-office and remote conferencing available |
LocationsMain Office- PA
8120 Old York Road, Suite 140 Elkins Park, PA 19027 New York Office 1619 3rd Ave. Suite 202 New York, NY 10128 (clinical trial evaluation only) |
Telephone NumberFax Number215-359-0630
|
Support UsQuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.
|
© 2020 Quietmind Foundation | All Rights Reserved | Quietmind Foundation is a not-for-profit 501(c)(3) organization.